There is longstanding evidence that immunoglobulin G (IgG) has a role in protection against
clinical malaria, and human antibodies of the cytophilic subclasses are thought to be …

Background Antigen-specific antibody-mediated immune responses play an important role in
natural protection against clinical malaria, but conflicting estimates of this association have …

Diarrhoeal disease attributable to enterotoxigenic Escherichia coli (ETEC) causes substantial
morbidity and mortality predominantly in paediatric populations in low- and middle-income …

Background GMZ2 is a recombinant protein malaria vaccine, comprising two blood-stage
antigens of Plasmodium falciparum, glutamate-rich protein and merozoite surface protein 3. …

Background The Global Hepatitis Health Sector Strategy is aiming for “elimination of viral
hepatitis as a public health threat” by 2030 [1], while enhanced elimination efforts for hepatitis …

Introduction Heterogeneous coverage threatens to compromise the effectiveness of immunization
programs in Zambia. Demand-creation initiatives are needed to address this; however, …

Introduction While in school, girls require an environment that is supportive of menstrual
hygiene management (MHM) in order to ensure regular school attendance and participation. …

Background Well-functioning health systems need to utilize data at all levels, from the
provider, to local and national-level decision makers, in order to make evidence-based and …

Malaria is still one of the major public health threats in sub-Saharan Africa. An effective
vaccine could be a sustainable control measure that can be integrated into existing health …

Clinical trials conducted in developing countries differ in many respects to those carried out
in the West; for example, they are usually conducted in vulnerable populations, focus mainly …